• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶-10/TIMP-2 结构与分析定义了 MMP/TIMP 复合物中保守的核心相互作用和多样的外位点相互作用。

Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.

机构信息

Department of Cancer Biology, Mayo Clinic Cancer Center, Jacksonville, Florida, United States of America.

出版信息

PLoS One. 2013 Sep 20;8(9):e75836. doi: 10.1371/journal.pone.0075836. eCollection 2013.

DOI:10.1371/journal.pone.0075836
PMID:24073280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3779175/
Abstract

Matrix metalloproteinases (MMPs) play central roles in vertebrate tissue development, remodeling, and repair. The endogenous tissue inhibitors of metalloproteinases (TIMPs) regulate proteolytic activity by binding tightly to the MMP active site. While each of the four TIMPs can inhibit most MMPs, binding data reveal tremendous heterogeneity in affinities of different TIMP/MMP pairs, and the structural features that differentiate stronger from weaker complexes are poorly understood. Here we report the crystal structure of the comparatively weakly bound human MMP-10/TIMP-2 complex at 2.1 Å resolution. Comparison with previously reported structures of MMP-3/TIMP-1, MT1-MMP/TIMP-2, MMP-13/TIMP-2, and MMP-10/TIMP-1 complexes offers insights into the structural basis of binding selectivity. Our analyses identify a group of highly conserved contacts at the heart of MMP/TIMP complexes that define the conserved mechanism of inhibition, as well as a second category of diverse adventitious contacts at the periphery of the interfaces. The AB loop of the TIMP N-terminal domain and the contact loops of the TIMP C-terminal domain form highly variable peripheral contacts that can be considered as separate exosite interactions. In some complexes these exosite contacts are extensive, while in other complexes the AB loop or C-terminal domain contacts are greatly reduced and appear to contribute little to complex stability. Our data suggest that exosite interactions can enhance MMP/TIMP binding, although in the relatively weakly bound MMP-10/TIMP-2 complex they are not well optimized to do so. Formation of highly variable exosite interactions may provide a general mechanism by which TIMPs are fine-tuned for distinct regulatory roles in biology.

摘要

基质金属蛋白酶(MMPs)在脊椎动物组织发育、重塑和修复中发挥核心作用。金属蛋白酶的内源性组织抑制剂(TIMPs)通过紧密结合 MMP 的活性位点来调节蛋白水解活性。虽然四种 TIMP 中的每一种都可以抑制大多数 MMP,但结合数据显示不同 TIMP/MMP 对的亲和力存在巨大的异质性,并且区分强复合物和弱复合物的结构特征还知之甚少。在这里,我们报告了以 2.1 Å 分辨率的相对较弱结合的人 MMP-10/TIMP-2 复合物的晶体结构。与先前报道的 MMP-3/TIMP-1、MT1-MMP/TIMP-2、MMP-13/TIMP-2 和 MMP-10/TIMP-1 复合物的结构比较提供了对结合选择性的结构基础的深入了解。我们的分析确定了 MMP/TIMP 复合物核心的一组高度保守的接触,这些接触定义了保守的抑制机制,以及界面外围的第二类多样化的偶然接触。TIMP N 端结构域的 AB 环和 TIMP C 端结构域的接触环形成高度可变的外围接触,可视为单独的附加结合位点相互作用。在一些复合物中,这些附加结合位点很广泛,而在其他复合物中,AB 环或 C 端结构域的接触大大减少,似乎对复合物稳定性贡献不大。我们的数据表明,附加结合位点可以增强 MMP/TIMP 结合,尽管在相对较弱结合的 MMP-10/TIMP-2 复合物中,它们没有很好地优化以实现这种结合。高度可变的附加结合位点的形成可能为 TIMP 提供了一种通用的机制,使其在生物学中精细调节不同的调节作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8cb/3779175/33b2697cfab9/pone.0075836.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8cb/3779175/61fd2fd46074/pone.0075836.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8cb/3779175/33b2697cfab9/pone.0075836.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8cb/3779175/61fd2fd46074/pone.0075836.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8cb/3779175/33b2697cfab9/pone.0075836.g005.jpg

相似文献

1
Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.基质金属蛋白酶-10/TIMP-2 结构与分析定义了 MMP/TIMP 复合物中保守的核心相互作用和多样的外位点相互作用。
PLoS One. 2013 Sep 20;8(9):e75836. doi: 10.1371/journal.pone.0075836. eCollection 2013.
2
Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.基质金属蛋白酶-10(MMP-10)与金属蛋白酶组织抑制剂 TIMP-1 和 TIMP-2 的相互作用:结合研究和晶体结构。
J Biol Chem. 2012 May 4;287(19):15935-46. doi: 10.1074/jbc.M112.341156. Epub 2012 Mar 16.
3
Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2.基质金属蛋白酶组织抑制因子(TIMP)结合的灵活性和可变性:胶原酶-3/MMP-13与TIMP-2复合物的X射线结构
J Mol Biol. 2007 Mar 2;366(4):1222-31. doi: 10.1016/j.jmb.2006.11.072. Epub 2006 Dec 1.
4
Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.膜型1-基质金属蛋白酶与金属蛋白酶组织抑制剂-2(可溶性前胶原酶A受体)形成的复合物的晶体结构。
EMBO J. 1998 Sep 1;17(17):5238-48. doi: 10.1093/emboj/17.17.5238.
5
Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).金属蛋白酶组织抑制剂2(TIMP-2)的序列基序决定了前明胶酶A(proMMP-2)与膜型金属蛋白酶1(MT1-MMP)的结合及激活。
Biochem J. 2003 Jun 15;372(Pt 3):799-809. doi: 10.1042/BJ20021573.
6
Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.限制金属蛋白酶组织抑制剂-1 N 结构域的特异性;明胶酶选择性抑制剂
Protein Sci. 2007 Sep;16(9):1905-13. doi: 10.1110/ps.072978507. Epub 2007 Jul 27.
7
Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.动态的域间相互作用有助于组织金属蛋白酶抑制剂对基质金属蛋白酶的抑制作用。
J Biol Chem. 2011 Jun 10;286(23):21002-12. doi: 10.1074/jbc.M110.200139. Epub 2011 Apr 25.
8
E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).TIMP-4的大肠杆菌表达以及与TIMP-1和TIMP-2的比较动力学研究:对TIMP与基质金属蛋白酶2(明胶酶A)相互作用的深入了解。
Biochemistry. 2002 Dec 17;41(50):15025-35. doi: 10.1021/bi026454l.
9
Utilization of a novel recombinant myoglobin fusion protein expression system to characterize the tissue inhibitor of metalloproteinase (TIMP)-4 and TIMP-2 C-terminal domain and tails by mutagenesis. The importance of acidic residues in binding the MMP-2 hemopexin C-domain.利用一种新型重组肌红蛋白融合蛋白表达系统,通过诱变来表征金属蛋白酶组织抑制剂(TIMP)-4和TIMP-2的C末端结构域及尾部。酸性残基在结合MMP-2血红素结合蛋白C结构域中的重要性。
J Biol Chem. 2002 Dec 13;277(50):48696-707. doi: 10.1074/jbc.M209177200. Epub 2002 Oct 8.
10
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.人工髋关节松动患者关节液中的基质金属蛋白酶和金属蛋白酶组织抑制剂
J Biomed Mater Res. 1999 Jun 5;45(3):175-83. doi: 10.1002/(sici)1097-4636(19990605)45:3<175::aid-jbm3>3.0.co;2-9.

引用本文的文献

1
Matrix metalloproteinase-driven epithelial-mesenchymal transition: implications in health and disease.基质金属蛋白酶驱动的上皮-间质转化:对健康与疾病的影响
J Transl Med. 2025 Apr 11;23(1):436. doi: 10.1186/s12967-025-06447-w.
2
Engineered TIMP2 with narrow MMP-9 specificity is an effective inhibitor of invasion and proliferation of triple-negative breast cancer cells.具有狭窄基质金属蛋白酶-9特异性的工程化组织金属蛋白酶抑制剂2是三阴性乳腺癌细胞侵袭和增殖的有效抑制剂。
J Biol Chem. 2024 Nov;300(11):107867. doi: 10.1016/j.jbc.2024.107867. Epub 2024 Oct 15.
3
Time trajectories and within-subject correlations of matrix metalloproteinases 3, 8, 9, 10, 12, and 13 serum levels and their ability to predict mortality in polytraumatized patients: a pilot study.

本文引用的文献

1
Unraveling hidden regulatory sites in structurally homologous metalloproteases.解析结构同源金属蛋白酶中的隐藏调控位点。
J Mol Biol. 2013 Jul 10;425(13):2330-46. doi: 10.1016/j.jmb.2013.04.009. Epub 2013 Apr 11.
2
PEGylation extends circulation half-life while preserving in vitro and in vivo activity of tissue inhibitor of metalloproteinases-1 (TIMP-1).聚乙二醇化延长了组织金属蛋白酶抑制剂-1(TIMP-1)的循环半衰期,同时保持了其在体外和体内的活性。
PLoS One. 2012;7(11):e50028. doi: 10.1371/journal.pone.0050028. Epub 2012 Nov 20.
3
Neuroprotection from tissue inhibitor of metalloproteinase-1 and its nanoparticles.
基质金属蛋白酶 3、8、9、10、12 和 13 的血清水平的时间轨迹和个体内相关性及其对多发伤患者死亡率的预测能力:一项初步研究。
Eur J Med Res. 2024 Apr 10;29(1):225. doi: 10.1186/s40001-024-01775-x.
4
Serum levels of matrix metalloproteinases 1, 2, and 7, and their tissue inhibitors 1, 2, 3, and 4 in polytraumatized patients: Time trajectories, correlations, and their ability to predict mortality.创伤患者血清中基质金属蛋白酶 1、2、7 及其组织抑制剂 1、2、3、4 的水平:时间轨迹、相关性及其对死亡率的预测能力。
PLoS One. 2024 Mar 8;19(3):e0300258. doi: 10.1371/journal.pone.0300258. eCollection 2024.
5
Structure and computation-guided yeast surface display for the evolution of TIMP-based matrix metalloproteinase inhibitors.基于结构和计算引导的酵母表面展示技术用于基于组织金属蛋白酶抑制剂的基质金属蛋白酶抑制剂的进化
Front Mol Biosci. 2023 Nov 23;10:1321956. doi: 10.3389/fmolb.2023.1321956. eCollection 2023.
6
Redefining metalloproteases specificity through network proteolysis.通过网络蛋白水解重新定义金属蛋白酶的特异性。
Trends Mol Med. 2024 Feb;30(2):147-163. doi: 10.1016/j.molmed.2023.11.001. Epub 2023 Nov 29.
7
Tissue inhibitors of metalloproteinases are proteolytic targets of matrix metalloproteinase 9.组织金属蛋白酶抑制剂是基质金属蛋白酶 9 的蛋白水解靶标。
Matrix Biol. 2023 Nov;123:59-70. doi: 10.1016/j.matbio.2023.09.002. Epub 2023 Oct 6.
8
The Continuing Saga of Tissue Inhibitor of Metalloproteinase 2: Emerging Roles in Tissue Homeostasis and Cancer Progression.组织金属蛋白酶抑制剂 2 的持续传奇:在组织动态平衡和癌症进展中的新角色。
Am J Pathol. 2023 Oct;193(10):1336-1352. doi: 10.1016/j.ajpath.2023.08.001. Epub 2023 Aug 11.
9
Designed Loop Extension Followed by Combinatorial Screening Confers High Specificity to a Broad Matrix MetalloproteinaseInhibitor.设计环延伸后进行组合筛选可赋予广谱基质金属蛋白酶抑制剂高特异性。
J Mol Biol. 2023 Jul 1;435(13):168095. doi: 10.1016/j.jmb.2023.168095. Epub 2023 Apr 15.
10
Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14.利用遗传密码扩展来修饰 N-TIMP2 对 MMP-2、MMP-9 和 MMP-14 的特异性。
Sci Rep. 2023 Mar 30;13(1):5186. doi: 10.1038/s41598-023-32019-3.
组织金属蛋白酶抑制剂-1 及其纳米颗粒的神经保护作用。
Neurochem Int. 2012 Dec;61(7):1065-71. doi: 10.1016/j.neuint.2012.07.023. Epub 2012 Aug 7.
4
Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential.基质金属蛋白酶-10 对于肺癌干细胞的维持、肿瘤起始和转移潜能是必需的。
PLoS One. 2012;7(4):e35040. doi: 10.1371/journal.pone.0035040. Epub 2012 Apr 24.
5
Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.基质金属蛋白酶-10(MMP-10)与金属蛋白酶组织抑制剂 TIMP-1 和 TIMP-2 的相互作用:结合研究和晶体结构。
J Biol Chem. 2012 May 4;287(19):15935-46. doi: 10.1074/jbc.M112.341156. Epub 2012 Mar 16.
6
MEROPS: the database of proteolytic enzymes, their substrates and inhibitors.MEROPs:蛋白水解酶、其底物和抑制剂数据库。
Nucleic Acids Res. 2012 Jan;40(Database issue):D343-50. doi: 10.1093/nar/gkr987. Epub 2011 Nov 15.
7
Tissue inhibitors of metalloproteinases.金属蛋白酶组织抑制剂。
Genome Biol. 2011 Nov 11;12(11):233. doi: 10.1186/gb-2011-12-11-233.
8
Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation.基质金属蛋白酶-10 促进 Kras 介导的支气管肺泡干细胞扩增和肺癌形成。
PLoS One. 2011;6(10):e26439. doi: 10.1371/journal.pone.0026439. Epub 2011 Oct 17.
9
MMP-10/stromelysin-2 promotes invasion of head and neck cancer.MMP-10/基质金属蛋白酶-2 促进头颈部癌症的侵袭。
PLoS One. 2011;6(10):e25438. doi: 10.1371/journal.pone.0025438. Epub 2011 Oct 5.
10
Pharmacokinetics and biodistribution of human serum albumin-TIMP-2 fusion protein using near-infrared optical imaging.利用近红外光学成像研究人血清白蛋白-TIMP-2 融合蛋白的药代动力学和生物分布。
J Pharm Pharm Sci. 2011;14(3):368-77. doi: 10.18433/j3h88d.